Latest Parkinson's disease Stories
NEW YORK, Feb. 20, 2014 /PRNewswire-USNewswire/ -- As medical researchers across disease states pursue better treatments, they all share one limiting factor.
Third Phase of Collaboration Aims to Unravel Mysteries of Disease by Identifying Disease Markers and Potential New Drug Targets FRAMINGHAM, Mass. and SUNNYVALE, Calif., Feb.
Also in This Edition: Jobs for Writers and Media Industry Blog Posts NEW YORK, Feb.
StemGenex is now providing access to its latest stem cell therapy for patients diagnosed with COPD through nebulized stem cells.
Mounting Evidence of Biological Similarities Inspires Funding Program to Advance Understanding of Two Most Common Brain Diseases CHICAGO, NEW YORK and TORONTO, Feb.
In the past, studies have shown that pesticides can cause an increased risk for the development of Parkinson’s disease. Recently, UCLA researchers have discovered that amount of risk varies with a person’s individual genetic makeup.
In-demand research study “Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management” worked out by GBI Research has been recently published
VALLEY VIEW, Ohio, Feb. 4, 2014 /PRNewswire/ -- Great Lakes NeuroTechnologies announced today they have received another allowance of claims from the U.S. Patent Office.
A new study shows that, when properly manipulated, a population of support cells found in the brain called astrocytes could provide a new and promising approach to treat Parkinson's disease.
- The act of sweetening by admixture of some saccharine substance.
More Images (1 images) »